Moreover, the expression of PLK1 can be useful in the diagnosis of patients with a high risk of metastasis, because the levels of PLK1 are higher in patients with metastatic cancer than in patients with primary cancer 17. The gene discussed is PLK1; the disease is metastatic malignant neoplasm.